BackJu Fu Tang Biotech Holdings , Ltd Overview

Ju Fu Tang Biotech Holdings , Ltd Current Assets

Track Ju Fu Tang Biotech Holdings , Ltd's current assets ($92M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$91.63M
↑ 14.25% YoYΔ $11.43M vs prior year quarter

Peer trimmed avg / median

Loading

Ju Fu Tang Biotech Holdings , Ltd Current Assets History

Loading

Ju Fu Tang Biotech Holdings , Ltd vs. peers: Current Assets Comparison

Loading

Ju Fu Tang Biotech Holdings , Ltd Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ju Fu Tang Biotech Holdings , Ltd (8217.HK) FAQ

Ju Fu Tang Biotech Holdings , Ltd's current assets stands at $92M as of March 2026. That compares with $80M in the prior-year period — up 14.3% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Ju Fu Tang Biotech Holdings , Ltd reported $92M in current assets versus $80M a year earlier — a 14.3% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $80M in the prior-year period — up 14.3% year over year. Sustained growth in current assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Ju Fu Tang Biotech Holdings , Ltd's current assets evolved across reporting periods, while the comparison chart places 8217.HK next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Industrials, current assets is commonly used to spot outliers. Ju Fu Tang Biotech Holdings , Ltd's reading of $92M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.